# MiFID II and UCITS: how Europe reshaped the business
On 3 January 2018, thousands of European fund managers woke up to a new reality: they could no longer get investment research "for free" from their brokers. Overnight, a bundled arrangement that had run the industry for decades became illegal. That single rule change, buried inside a regulation called MiFID II, forced asset managers to decide who pays for research, how much, and whether to charge clients or eat the cost themselves. Most ate it.
This is what modern EU regulation does. It does not just police behavior. It rewrites pricing, distribution, and product design. Let us follow one imaginary but realistic vehicle, a European equity fund domiciled in Luxembourg, to see how.
Two frameworks dominate European asset management.
UCITS (Undertakings for Collective Investment in Transferable Securities) is the EU's flagship regime for retail funds. First introduced in 1985 and repeatedly updated, it sets product rules: what a fund can hold, how much it can borrow, how liquid it must be. A UCITS fund can be sold to retail investors across all 27 EU member states under a single authorization, the "passport." That passport is why UCITS became a global export brand, sold in Asia and Latin America too.
MiFID II (Markets in Financial Instruments Directive II), effective 2018, governs conduct: how firms trade, how they disclose costs, how they interact with clients, and how they pay for research. Where UCITS shapes the product, MiFID II shapes the sale and the plumbing.
The supervisor tying it together is ESMA (European Securities and Markets Authority), the EU-level body that writes technical standards and coordinates national regulators like Germany's BaFin, France's AMF, and Luxembourg's CSSF.
Our Luxembourg equity fund is a UCITS. Before it holds a single share, the rulebook has already shaped it.
UCITS caps concentration. A fund can invest no more than 10% of assets in a single issuer, and positions above 5% cannot together exceed 40% of the portfolio. This is the "5/10/40 rule."
Worked example: our fund has 200 million euros. It wants a big conviction bet on one large-cap stock. The maximum it can hold in that name is 10%, so 20 million euros. If it wants three such 5%-plus positions, they can total at most 80 million euros (40%). The regulation, not the manager's conviction, sets the ceiling.
UCITS funds must offer redemption at least twice a month in practice (regulators expect this), and portfolios must be liquid enough to meet it. That pushes our fund toward listed equities and away from, say, private or thinly traded names. Product design follows the liquidity rule.
Under UCITS rules, a fund's global exposure from derivatives generally cannot exceed 100% of net asset value using the "commitment approach." In plain terms, a UCITS cannot double its market exposure through derivatives the way a hedge fund might. If our manager wants leverage of 3x, UCITS is the wrong wrapper. That deal goes into an AIF (Alternative Investment Fund), governed by a separate regime, AIFMD (Alternative Investment Fund Managers Directive), aimed at professional investors.
The lesson: the regulatory wrapper you choose defines the product you are allowed to build.
You can read ESMA's plain summary of the UCITS framework on its official investor page.
Now the fund starts trading, and MiFID II takes over.
Before 2018, a broker executed trades and threw in research (analyst reports, company access, models) at no explicit charge. The cost was hidden inside trading commissions. MiFID II banned this bundling for most cases. Research now has to be paid for separately, either:
What happened in practice? Most large managers chose to absorb research costs themselves rather than bill clients. Industry commentary widely reported sharp falls in research budgets and shrinking analyst coverage of smaller companies (these are estimates and vary by source). Fewer buyers meant less coverage of small and mid caps.
Our fund now pays a specialist research provider a fixed annual fee out of its own P&L. That is a direct cost the fund did not carry in 2017. Pricing changed because the rule changed.
Regulation is not static. Recognizing that unbundling had hurt small-cap research, EU reforms (part of the Listing Act package finalized around 2024) allowed managers more flexibility to re-bundle research and execution payments, provided disclosure obligations are met. The UK, post-Brexit, moved in a similar direction. So by 2026 the picture is more mixed: full unbundling is no longer mandatory in the same rigid way, but transparency requirements remain. Always check the current national rules.
MiFID II forced granular cost disclosure. Investors must see, before and after investing, the total cost of ownership: management fees, transaction costs, and entry or exit charges, expressed in cash and percentage terms. Combined with the PRIIPs rules (Packaged Retail and Insurance-based Investment Products), which require a standardized KID (Key Information Document), our fund must hand every retail buyer a short, comparable summary of risk, cost, and possible returns.
MiFID II also demands "best execution": firms must take all sufficient steps to get the best result for clients across price, cost, speed, and likelihood of settlement. Our fund's trading desk must document venue choices and be able to prove it. This is a compliance workload, not just a principle.
Knowledge check
1. The excerpt describes the MiFID II research-unbundling rule as an example of how EU regulation goes beyond policing behavior. What broader concept does this illustrate?
2. A firm needs to decide whether a given rule applies to how a fund is constructed versus how it is sold to clients. Based on the division described, which framework governs which domain?
3. Why is the UCITS 'passport' significant for an asset manager's business strategy?
4. Select ALL correct answers about the role and structure of European securities supervision as described.
Select all the correct answers.
5. Select ALL correct answers about how UCITS constraints affect a fund before it holds any assets.
Select all the correct answers.
Zoom out from our fund and the structural effects are clear.
Distribution changed. Cost transparency exposed how much of a retail investor's return was eaten by fees and by commissions paid to distributors. This accelerated the shift toward low-cost passive funds and ETFs (Exchange Traded Funds), and pushed active managers to justify their fees. Players like BlackRock, Amundi, and Vanguard, already strong in low-cost products, benefited from the transparency spotlight.
Product design consolidated. The UCITS brand became so trusted that firms designed globally around it. Ireland and Luxembourg became the dominant domiciles for cross-border UCITS funds, an established and widely cited fact. If you want to sell a fund in eight European markets plus Singapore, you build a Luxembourg UCITS.
Research became an industry. Independent research providers emerged to sell what brokers once gave away. Analyst coverage of small caps thinned, a genuine policy concern that drove the 2024 reforms.
Scale won. Compliance is expensive: KIDs, cost reports, best-execution monitoring, and RPA administration all cost money regardless of fund size. Larger managers absorb this more easily, reinforcing consolidation. This is a real and repeatedly observed dynamic across EU financial regulation.
Even a US or Asian manager cannot ignore these rules. To sell into Europe, you need a UCITS or an AIF and you inherit these constraints. Global firms often run parallel product lines: US mutual funds under SEC rules, and UCITS funds under EU rules, for the same strategy. Understanding both is table stakes for anyone operating internationally.
*This lesson is educational and not investment or legal advice. Verify current rules with ESMA and the relevant national regulator.*